{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:23:58Z","timestamp":1795134238221,"version":"4.10.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>T-cells play a crucial role in progression of autoimmunity, including vitiligo, yet the initial steps triggering their activation and tissue damage remain unknown. Here we demonstrate increased presence of type-1 innate lymphoid cells (NK and ILC1)-producing interferon gamma (IFN\u03b3) in the blood and in non-lesional skin of vitiligo patients. Melanocytes of vitiligo patients have strong basal expression of chemokine-receptor-3 (CXCR3) isoform B which is directly regulated by IFN\u03b3. CXCR3B activation by CXCL10 at the surface of cultured human melanocytes induces their apoptosis. The remaining melanocytes, activated by the IFN\u03b3 production, express co-stimulatory markers which trigger T-cell proliferation and subsequent anti-melanocytic immunity. Inhibiting the CXCR3B activation prevents this apoptosis and the further activation of T cells. Our results emphasize the key role of CXCR3B in apoptosis of melanocytes and identify CXCR3B as a potential target to prevent and to treat vitiligo by acting at the early stages of melanocyte destruction.<\/jats:p>","DOI":"10.1038\/s41467-019-09963-8","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T06:04:14Z","timestamp":1557986654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-2369","authenticated-orcid":false,"given":"Meri K.","family":"Tulic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9839-4332","authenticated-orcid":false,"given":"Yann","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-8048","authenticated-orcid":false,"given":"Arnaud","family":"Jacquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-4164","authenticated-orcid":false,"given":"Carmelo","family":"Luci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cardot-Leccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanene","family":"Hadhiri-Bzioueche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Abbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3672-6658","authenticated-orcid":false,"given":"Ma\u00e9va","family":"Gesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sormani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Regazzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-864X","authenticated-orcid":false,"given":"Guillaume E.","family":"Beranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-5638","authenticated-orcid":false,"given":"Cedric","family":"Lereverend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Khemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ballotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"9963_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/jid.2011.321","volume":"132","author":"RA Spritz","year":"2012","unstructured":"Spritz, R. A. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J. Invest. Dermatol. 132, 268\u2013273 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng.2272","volume":"44","author":"Y Jin","year":"2012","unstructured":"Jin, Y. et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat. Genet. 44, 676\u2013680 (2012).","journal-title":"Nat. Genet."},{"key":"9963_CR3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/ng.3680","volume":"48","author":"Y Jin","year":"2016","unstructured":"Jin, Y. et al. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat. Genet. 48, 1418\u20131424 (2016).","journal-title":"Nat. Genet."},{"key":"9963_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/jid.2013.540","volume":"134","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee, S. et al. A quantitative increase in regulatory T cells controls development of vitiligo. J. Invest. Dermatol. 134, 1285\u20131294 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR5","doi-asserted-by":"publisher","first-page":"174ra128","DOI":"10.1126\/scitranslmed.3005127","volume":"5","author":"JA Mosenson","year":"2013","unstructured":"Mosenson, J. A. et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci. Transl. Med. 5, 174ra128 (2013).","journal-title":"Sci. Transl. Med"},{"key":"9963_CR6","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris, J. E. et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J. Invest. Dermatol. 132, 1869\u20131876 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR7","doi-asserted-by":"publisher","first-page":"223ra223","DOI":"10.1126\/scitranslmed.3007811","volume":"6","author":"M Rashighi","year":"2014","unstructured":"Rashighi, M. et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci. Transl. Med. 6, 223ra223 (2014).","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"9963_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"Jillian M. Richmond","year":"2017","unstructured":"Richmond J. M. et al. Keratinocyte-derived chemokines orchestrate T cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. J. Invest. Dermatol. 137, 350\u2013358 (2017).","journal-title":"Journal of Investigative Dermatology"},{"key":"9963_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/bjd.14416","volume":"174","author":"XX Wang","year":"2016","unstructured":"Wang, X. X. et al. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo. Br. J. Dermatol. 174, 1318\u20131326 (2016).","journal-title":"Br. J. Dermatol."},{"key":"9963_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jid.2016.10.048","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond, J. M. et al. CXCR3 depleting antibodies prevent and reverse vitiligo in mice. J. Invest. Dermatol. 137, 982\u2013985 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR11","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/jid.2015.335","volume":"135","author":"C Regazzetti","year":"2015","unstructured":"Regazzetti, C. et al. Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients. J. Invest. Dermatol. 135, 3105\u20133114 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR12","doi-asserted-by":"publisher","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","volume":"7","author":"R Yu","year":"2012","unstructured":"Yu, R. et al. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PloS ONE 7, e51040 (2012).","journal-title":"PloS ONE"},{"key":"9963_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nm.3892","volume":"21","author":"GF Sonnenberg","year":"2015","unstructured":"Sonnenberg, G. F. & Artis, D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 21, 698\u2013708 (2015).","journal-title":"Nat. Med"},{"key":"9963_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"9963_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.imlet.2012.04.014","volume":"145","author":"G Bernardini","year":"2012","unstructured":"Bernardini, G., Gismondi, A. & Santoni, A. Chemokines and NK cells: regulators of development, trafficking and functions. Immunol. Lett. 145, 39\u201346 (2012).","journal-title":"Immunol. Lett."},{"key":"9963_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0190-9622(86)70085-6","volume":"14","author":"RM Halder","year":"1986","unstructured":"Halder, R. M., Walters, C. S., Johnson, B. A., Chakrabarti, S. G. & Kenney, J. A. Jr. Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study. J. Am. Acad. Dermatol. 14, 733\u2013737 (1986).","journal-title":"J. Am. Acad. Dermatol."},{"key":"9963_CR17","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.jid.2016.07.017","volume":"136","author":"MC Bruggen","year":"2016","unstructured":"Bruggen, M. C. et al. In situ mapping of innate lymphoid cells in human skin: evidence for remarkable differences between normal and inflamed skin. J. Invest. Dermatol. 136, 2396\u20132405 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","volume":"46","author":"Y Simoni","year":"2017","unstructured":"Simoni, Y. et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46, 148\u2013161 (2017).","journal-title":"Immunity"},{"key":"9963_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","volume":"25","author":"JM Richmond","year":"2013","unstructured":"Richmond, J. M., Frisoli, M. L. & Harris, J. E. Innate immune mechanisms in vitiligo: danger from within. Curr. Opin. Immunol. 25, 676\u2013682 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"9963_CR20","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","volume":"151","author":"IC Le Poole","year":"1993","unstructured":"Le Poole, I. C. et al. A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J. Immunol. 151, 7284\u20137292 (1993).","journal-title":"J. Immunol."},{"key":"9963_CR21","first-page":"454","volume":"15","author":"Y Lu","year":"2002","unstructured":"Lu, Y., Zhu, W. Y., Tan, C., Yu, G. H. & Gu, J. X. Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes. Pigment cell research \/ sponsored by the European Society for Pigment Cell Research and the International Pigment Cell. Society 15, 454\u2013460 (2002).","journal-title":"Society"},{"key":"9963_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jdermsci.2017.03.008","volume":"87","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus. J. Dermatol. Sci. 87, 50\u201359 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"9963_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/bjd.12006","volume":"168","author":"Y Harmelin","year":"2013","unstructured":"Harmelin, Y. et al. Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo. Br. J. Dermatol. 168, 663\u2013664 (2013).","journal-title":"Br. J. Dermatol."},{"key":"9963_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ni.3553","volume":"17","author":"F Vely","year":"2016","unstructured":"Vely, F. et al. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17, 1291\u20131299 (2016).","journal-title":"Nat. Immunol."},{"key":"9963_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","volume":"4","author":"KU Schallreuter","year":"1999","unstructured":"Schallreuter, K. U. et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Invest. Dermatol Symp. Proc. 4, 91\u201396 (1999).","journal-title":"J. Invest. Dermatol Symp. Proc."},{"key":"9963_CR26","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/jid.2014.152","volume":"134","author":"Z Jian","year":"2014","unstructured":"Jian, Z. et al. Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J. Invest. Dermatol. 134, 2221\u20132230 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR27","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jid.2008.45","volume":"128","author":"CJ Denman","year":"2008","unstructured":"Denman, C. J. et al. HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J. Invest. Dermatol. 128, 2041\u20132048 (2008).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/pcmr.12208","volume":"27","author":"JA Mosenson","year":"2014","unstructured":"Mosenson, J. A. et al. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell Melanoma Res. 27, 209\u2013220 (2014).","journal-title":"Pigment Cell Melanoma Res."},{"key":"9963_CR29","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/bjd.15151","volume":"176","author":"JY Kim","year":"2017","unstructured":"Kim, J. Y., Lee, E. J., Seo, J. & Oh, S. H. Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Br. J. Dermatol. 176, 1558\u20131568 (2017).","journal-title":"Br. J. Dermatol."},{"key":"9963_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2567.2010.03384.x","volume":"132","author":"A Korniejewska","year":"2011","unstructured":"Korniejewska, A., McKnight, A. J., Johnson, Z., Watson, M. L. & Ward, S. G. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology 132, 503\u2013515 (2011).","journal-title":"Immunology"},{"key":"9963_CR31","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1074\/jbc.M113.508044","volume":"289","author":"M Balan","year":"2014","unstructured":"Balan, M. & Pal, S. A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation. J. Biol. Chem. 289, 3126\u20133137 (2014).","journal-title":"J. Biol. Chem."},{"key":"9963_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","volume":"138","author":"K Boniface","year":"2018","unstructured":"Boniface, K. et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. J. Invest. Dermatol. 138, 355\u2013364 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fmed.2018.00271","volume":"5","author":"PT Kuo","year":"2018","unstructured":"Kuo, P. T. et al. The role of CXCR3 and its chemokine ligands in skin disease and cancer. Front. Med. 5, 271 (2018).","journal-title":"Front. Med."},{"key":"9963_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1124\/mol.116.105502","volume":"90","author":"YA Berchiche","year":"2016","unstructured":"Berchiche, Y. A. & Sakmar, T. P. CXC chemokine receptor 3 alternative splice variants selectively activate different signaling pathways. Mol. Pharm. 90, 483\u2013495 (2016).","journal-title":"Mol. Pharm."},{"key":"9963_CR35","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20021897","volume":"197","author":"L Lasagni","year":"2003","unstructured":"Lasagni, L. et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537\u20131549 (2003).","journal-title":"J. Exp. Med."},{"key":"9963_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11151-x","volume":"7","author":"K Boye","year":"2017","unstructured":"Boye, K., Billottet, C., Pujol, N., Alves, I. D. & Bikfalvi, A. Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR). Sci. Rep. 7, 10703 (2017).","journal-title":"Sci. Rep."},{"key":"9963_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1245\/ASO.2006.03.038","volume":"13","author":"ED Feldman","year":"2006","unstructured":"Feldman, E. D. et al. Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells. Ann. Surg. Oncol. 13, 125\u2013133 (2006).","journal-title":"Ann. Surg. Oncol."},{"key":"9963_CR38","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/jid.2015.25","volume":"135","author":"RY Wagner","year":"2015","unstructured":"Wagner, R. Y. et al. Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo. J. Invest. Dermatol. 135, 1810\u20131819 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"9963_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","volume":"35","author":"RA Spritz","year":"2017","unstructured":"Spritz, R. A. & Andersen, G. H. Genetics of vitiligo. Dermatol Clin. 35, 245\u2013255 (2017).","journal-title":"Dermatol Clin."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09963-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09963-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09963-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:48:47Z","timestamp":1694868527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09963-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9963"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09963-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735781509.793568925","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2178"}}